Skip to content

The Natural History of Chronic Pancreatitis

The Natural History of Chronic Pancreatitis: A Multicenter Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03324698
Enrollment
4000
Registered
2017-10-30
Start date
2000-01-01
Completion date
2027-01-31
Last updated
2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pancreatitis, Complication, Risk Factors

Brief summary

Chronic pancreatitis (CP) is a disease characterized by inflammation and their replacement by fibrotic tissue. The destruction of pancreatic function and structure are the main complications. This retrospective-prospective, multicenter, cohort study was conducted. This study aimed to observe the natural history of CP in China, analyse the risk factors for CP complications, and establish individual predictions.

Detailed description

In order to track changes consistently throughout the course of CP and facilitate the evaluation and study of CP, a dedicated database, CP Database (version number 2.1, YINMA Information Technology Inc., Shanghai, China), was established to collect clinical data of CP patients who were admitted to our centers. Data befor CP Database established were retrospectively collected according to the electronic medical record system and complemented through telephone, letter, and e-mail inquiries. Data were prospectively collected since CP Database was established. The following information was documented in detail: demographic data (age, sex, birthplace, et al), course of CP, medical history, history of other diseases, smoking and alcohol history, family history of pancreatic diseases and diabetes mellitus (DM), laboratory and imaging findings, and treatment strategy.

Interventions

None listed

Sponsors

Changhai Hospital
Lead SponsorOTHER
Shenzhen People's Hospital
CollaboratorOTHER
Zhongda Hospital
CollaboratorOTHER
The Affiliated Hospital of Qingdao University
CollaboratorOTHER
Yangzhou University
CollaboratorOTHER
Jinling Hospital, China
CollaboratorOTHER
The First People's Hospital of Hefei
CollaboratorOTHER
Zaozhuang Central Hospital of Shandong Health Group
CollaboratorUNKNOWN
The Fifth Medical Center of the PLA General Hospital
CollaboratorUNKNOWN
The Third People's Hospital of Chengdu
CollaboratorOTHER
Ruijin Hospital
CollaboratorOTHER
900th Hospital of PLA Joint Logistic Support Force
CollaboratorOTHER
Air Force Medical Center of PLA
CollaboratorUNKNOWN
The Fifth Medical Center of Chinese People's Liberation Army General Hospital
CollaboratorUNKNOWN
The Affiliated Hospital of Technical University of Munich
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with chronic pancreatitis according to Asia-Pacific consensus

Exclusion criteria

* Pancreatic cancer diagnosed within 2 years after the diagnosis of chronic pancreatitis * Groove pancreatitis * Autoimmune pancreatitis

Design outcomes

Primary

MeasureTime frameDescription
Pancreatic cancerDec 31, 2017Pancreatic cancer developed in chronic pancreatitis patients
Diabetes mellitusDec 31, 2017Endocrine insufficiency developed in chronic pancreatitis patients
SteatorrheaDec 31, 2017Exocrine insufficiency developed in chronic pancreatitis patients
Pancreatic pseudocystDec 31, 2017Pancreatic pseudocyst developed in chronic pancreatitis patients
Common bile duct strictureDec 31, 2017Common bile duct stricture developed in chronic pancreatitis patients

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026